{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:21:10Z","timestamp":1786998070394,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007773","name":"Danone\/Nutricia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi\/Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hipp"},{"name":"Ferrero"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.waojou.2020.100445","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T09:33:38Z","timestamp":1600421618000},"page":"100445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oral immunotherapy for peanut allergy: The con argument"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2549-0523","authenticated-orcid":false,"given":"Alessandro","family":"Fiocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Artesani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Dahdah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Mennini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2020.100445_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1067\/mai.2002.128802","article-title":"Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts","volume":"110","author":"Grundy","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cea.13088","article-title":"Prevalence and longitudinal trends of food allergy during childhood and adolescence: results of the Isle of Wight Birth Cohort study","volume":"48","author":"Venkataraman","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100445_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/1744666X.2020.1693264","article-title":"Evaluation of the epidemiology of peanut allergy in the United Kingdom","volume":"15","author":"Scott","year":"2019","journal-title":"Expet Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2020.100445_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and severity of food allergies among US adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.waojou.2020.100445_bib5","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jaci.2010.03.029","article-title":"US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up","volume":"125","author":"Sicherer","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.socscimed.2013.04.031","article-title":"Parsing the peanut panic: the social life of a contested food allergy epidemic","volume":"90","author":"Waggoner","year":"2013","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.waojou.2020.100445_bib7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/all.12423","article-title":"EAACI Food Allergy and Anaphylaxis Guidelines Group. Prevalence of common food allergies in Europe: a systematic review and meta-analysis","volume":"69","author":"Nwaru","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100445_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaip.2017.06.001","article-title":"Low food allergy prevalence despite delayed introduction of allergenic foods-data from the GUSTO Cohort","volume":"6","author":"Tham","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100445_bib9","doi-asserted-by":"crossref","first-page":"100089","DOI":"10.1016\/j.waojou.2019.100089","article-title":"Challenges of managing food allergy in the developing world","volume":"12","author":"Hossny","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100445_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1067\/mpd.2000.109376","article-title":"The natural history of peanut allergy in young children and its association with serum peanut-specific IgE","volume":"137","author":"Vander Leek","year":"2000","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.waojou.2020.100445_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100445_bib12","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100445_bib13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(00)67313-0","article-title":"A\u00a0case of egg poisoning","volume":"171","author":"Schofield","year":"1908","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100445_bib14","first-page":"52","article-title":"Food allergy in children: results of a standardized protocol for oral desensitization","volume":"45","author":"Patriarca","year":"1998","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.waojou.2020.100445_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaci.2007.10.029","article-title":"Specific oral tolerance induction in children with very severe cow's milk\u2013induced reactions","volume":"121","author":"Longo","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1398-9995.2007.01501.x","article-title":"Specific oral tolerance induction in food allergy in children: efficacy and clinical pattern of reaction","volume":"62","author":"Staden","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100445_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0091-6749(97)80006-1","article-title":"Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract","volume":"99","author":"Nelson","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/all.13124","article-title":"Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"72","author":"Nurmatov","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100445_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100445_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100445_bib21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomized, double blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100445_bib22","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100445_bib23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A\u00a0randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9925","key":"10.1016\/j.waojou.2020.100445_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100445_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/all.13330","article-title":"The longitudinal impact of probiotic and peanut oral immunotherapy on health-related quality of life","volume":"73","author":"Dunn Galvin","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100445_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2352-4642(17)30041-X","article-title":"Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hsiao","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.waojou.2020.100445_bib28","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","article-title":"A\u00a0randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy","volume":"135","author":"Narisety","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaip.2017.09.016","article-title":"Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"6","author":"Bird","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100445_bib30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaip.2018.10.048","article-title":"Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy","volume":"7","author":"Blumchen","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100445_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/all.13604","article-title":"Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy","volume":"74","author":"Reier-Nilsen","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100445_bib32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/cea.13148","article-title":"Peanut gastrointestinal delivery oral immunotherapy in adolescents: results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study)","volume":"48","author":"Fauquert","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"5, suppl ment","key":"10.1016\/j.waojou.2020.100445_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2018.09.010","article-title":"Age-related findings from the peanut allergy oral immunotherapy study of AR101 for desensitization (PALISADE) study","volume":"121","author":"Burks","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2009.05.027","article-title":"Summary of the 2008 national Institute of allergy and infectious diseases-US food and drug administration workshop on food allergy clinical trial design","volume":"124","author":"Plaut","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib35","article-title":"Cfr - code of federal regulations","volume":"vol. 21","year":"2018"},{"issue":"4","key":"10.1016\/j.waojou.2020.100445_bib38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jaci.2019.10.021","article-title":"Conflicting verdicts on peanut oral immunotherapy from the Institute for clinical and economic review and US food and drug administration advisory committee: where do we go from here?","volume":"145","author":"Eiwegger","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib39","doi-asserted-by":"crossref","first-page":"44-7","DOI":"10.1111\/j.1399-3038.1995.tb00257.x","article-title":"Systemic reactions to\u00a0specific immunotherapy in children with respiratory allergy:\u00a0a prospective study","volume":"6","author":"Businco","year":"1995","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.anai.2016.01.015","article-title":"Local and systemic reactions to subcutaneous allergen immunotherapy: ten years' experience in a pediatric clinic","volume":"116","author":"Nacaroglu","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaip.2016.08.017","article-title":"Epinephrine use in clinical trials of sublingual immunotherapy tablets","volume":"5","author":"Nolte","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100445_bib42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0091270004273680","article-title":"Origin and uses of primum non nocere-above all, do no harm!","volume":"45","author":"Smith","year":"2005","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.waojou.2020.100445_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41598-019-56961-3","article-title":"Adverse events associated with peanut oral immunotherapy in children - a\u00a0systematic review and meta-analysis","volume":"10","author":"Grzeskowiak","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.waojou.2020.100445_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1081-1206(10)60205-0","article-title":"Incremental prognostic factors associated with cow's milk allergy outcomes in infant and child referrals: the Milan Cow's Milk Allergy Cohort study","volume":"101","author":"Fiocchi","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib45","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0140-6736(19)31816-1","article-title":"Sustained unresponsiveness in peanut oral immunotherapy","volume":"394","author":"van Ree","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100445_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/ACI.0000000000000368","article-title":"Severe food allergies: can they be considered rare diseases?","volume":"17","author":"Fiocchi","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/ACI.0000000000000357","article-title":"Use of biologics in severe food allergies","volume":"17","author":"Fiocchi","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib48","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jaci.2016.08.017","article-title":"Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults","volume":"139","author":"Jones","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib49","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2019.07.030","article-title":"Long-term sublingual immunotherapy for peanut allergy in children: clinical and immunologic evidence of desensitization","volume":"144","author":"Kim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaci.2019.08.036","article-title":"Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity","volume":"145","author":"Tscheppe","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2012.11.011","article-title":"Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial","volume":"131","author":"Fleischer","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2020.100445_bib52","first-page":"135","article-title":"Sublingual and patch immunotherapy for food allergy","volume":"40","author":"Waldron","year":"2020","journal-title":"Immunol Allergy Clin"},{"issue":"6","key":"10.1016\/j.waojou.2020.100445_bib53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/ACI.0000000000000587","article-title":"Oral and sublingual immunotherapy for food allergy","volume":"19","author":"Nowak-Wegrzyn","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib54","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/all.13687","article-title":"Chemically modified peanut extract shows increased safety while maintaining immunogenicity","volume":"74","author":"Van der Kleij","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100445_bib55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1710-1492-10-7","article-title":"Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab","volume":"10","author":"B\u00e9gin","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100445_bib57","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jaip.2019.01.023","article-title":"Impact of omalizumab on food allergy in patients treated for asthma: a real-life study","volume":"7","author":"Fiocchi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100445_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2222.2011.03948.x","article-title":"Oral immunotherapy for IgE-mediated cow's milk allergy: a systematic review and meta-analysis","volume":"42","author":"Bro\u017cek","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2020.100445_bib60","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.anai.2020.01.030","article-title":"Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies","volume":"125","author":"Greenhawt","year":"2020","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:42:19Z","timestamp":1761849739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455120303483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1939455120303483"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100445","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral immunotherapy for peanut allergy: The con argument","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100455","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100445"}}